GENE ONLINE|News &
Opinion
Blog

RNA Therapeutics
Partnerships Ginkgo BioworksRNA Therapeutics
Ginkgo Bioworks and Pfizer Forge $331 Million Collaboration for RNA-Based Drug Discovery
2023-09-29
R&D Amyotrophic Lateral Sclerosis
Repairing Genetic Mutations in Neurological Diseases with RNA Targeting Strategy
2022-11-25
Special ASGCTJapan
Cell and Gene Therapy Landscape in Japan is Moving Beyond Oncology
2022-05-27
Special ASGCT
RNA Therapeutics Beyond Vaccines
2022-05-19
Deals RNAi
Arrowhead, Vivo Form Visirna to Take on China RNAi Market
2022-04-26
Special RNA
Scientists Engineer RNA Switches for Targeted Delivery of Gene Therapy and RNA Therapeutics
2021-11-07
Interviews RNA Editing
Current Challenges and Future Opportunities of Artificial RNA Editing – An Interview with Professor Toshifumi Tsukahara
2021-08-26
Deals Immuno-oncology
Moderna Banks on Autolus’ Proprietary Tech to Advance Immuno-Oncology Pipeline
2021-08-03
JPM Healthcare Conference: Shape, Korro, and Ionis Present Advances in RNA Therapeutics
2021-01-18
Trials & Approvals Liver Enzyme
Alnylam Receives FDA Nod for its Third Rare Disease Drug
2020-11-25
New Frontiers in Therapeutics
2020-07-25Partner
A Rising Hope in Therapeutics — From Precision Medicine to Advanced Therapies
2020-07-19
R&D
Biogen’s SMA Drug, Spinraza Continues to Show Benefits in Pre-Symptomatic Patients
2020-06-14
In-Depth RNA Therapeutics
The Rejuvenated Promise of RNA Therapeutics
2020-01-07
Technology
RNA Therapeutics: An Overview
2019-12-25
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
READ MORE
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top